Pasithea Therapeutics Corp. (NasdaqCM: KTTA)
Health Care · Biotechnology · US
$0.54
+12.26% today · -32.4% 1Y
Pasithea Therapeutics Corp. (NasdaqCM: KTTA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.06M and employs 5 people.
Over the last twelve months the share price has lost 32.4%, trading between 0.28 and 2.06.
Tweenvest scores Pasithea Therapeutics Corp. across four factors: quality 26/100. Its strongest factor is quality.
KTTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.06M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- $2.06
- 52-week low
- $0.28
- Avg volume (3M)
- —
- Shares outstanding
- 33.41M
- Employees
- 5
- Next earnings
- —
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
- Founded
- 2020
- Listed since
- Sep 15, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.